Search research articles
Contact Us
Filters
Showing results (91-100 of 225) with videos related to
Page
of 23
Sort By:
Journal of Thrombosis and Thrombolysis
|
January 19, 2016
Guidance for the management of venous thrombosis in unusual sites
Walter Ageno, Jan Beyer-Westendorf, David A Garcia, et al.
Thrombosis Research
|
February 7, 2018
Effectiveness and safety of outpatient rivaroxaban versus warfarin for treatment of venous thromboembolism in patients with a known primary hypercoagulable state
Craig I Coleman, Alexander G G Turpie, Thomas J Bunz, et al.
The American Journal of Medicine
|
December 25, 2018
Impact of Prolonged Anticoagulation with Rivaroxaban on Provoked Venous Thromboembolism Recurrence: IMPROVE-VTE
Craig I Coleman, Alexander G G Turpie, Thomas J Bunz, et al.
Thrombosis Research
|
May 11, 2020
Anticoagulation with direct factor Xa inhibitors in transplant recipients: Results from the DRESDEN NOAC REGISTRY (NCT01588119)
Jan Beyer-Westendorf, Sandra Marten, Christiane Naue, et al.
Thrombosis Journal
|
January 1, 2020
Evaluation of unmet clinical needs in prophylaxis and treatment of venous thromboembolism in at-risk patient groups: pregnancy, elderly and obese patients
Benjamin Brenner, Roopen Arya, Jan Beyer-Westendorf, et al.
Thrombosis Research
|
June 16, 2023
Clinical effectiveness and safety of edoxaban in obese patients - Results of the prospective Dresden NOAC Registry (NCT01588119)
Luise Tittl, Christina Köhler, Sandra Marten, et al.
Thrombosis Research
|
May 27, 2022
Effectiveness and safety of edoxaban therapy in daily-care patients with atrial fibrillation. Results from the DRESDEN NOAC REGISTRY
Christina Köhler, Luise Tittl, Sandra Marten, et al.
Thrombosis and Haemostasis
|
May 22, 2015
Selection, management, and outcome of vitamin K antagonist-treated patients with atrial fibrillation not switched to novel oral anticoagulants. Results from the Dresden NOAC registry
Franziska Michalski, Luise Tittl, Sebastian Werth, et al.
Thrombosis Journal
|
September 7, 2018
COSIMO - patients with active cancer changing to rivaroxaban for the treatment and prevention of recurrent venous thromboembolism: a non-interventional study
Alexander T Cohen, Anthony Maraveyas, Jan Beyer-Westendorf, et al.
Thrombosis Journal
|
April 24, 2019
Evaluation of unmet clinical needs in prophylaxis and treatment of venous thromboembolism in high-risk patient groups: cancer and critically ill
Benjamin Brenner, Russell Hull, Roopen Arya, et al.
Page
of 23
Search research articles
Search
Showing results (91-100 of 225) with videos related to
Sort By:
Page
of 23
Journal of Thrombosis and Thrombolysis
|
January 19, 2016
Guidance for the management of venous thrombosis in unusual sites
Walter Ageno, Jan Beyer-Westendorf, David A Garcia, et al.
Thrombosis Research
|
February 7, 2018
Effectiveness and safety of outpatient rivaroxaban versus warfarin for treatment of venous thromboembolism in patients with a known primary hypercoagulable state
Craig I Coleman, Alexander G G Turpie, Thomas J Bunz, et al.
The American Journal of Medicine
|
December 25, 2018
Impact of Prolonged Anticoagulation with Rivaroxaban on Provoked Venous Thromboembolism Recurrence: IMPROVE-VTE
Craig I Coleman, Alexander G G Turpie, Thomas J Bunz, et al.
Thrombosis Research
|
May 11, 2020
Anticoagulation with direct factor Xa inhibitors in transplant recipients: Results from the DRESDEN NOAC REGISTRY (NCT01588119)
Jan Beyer-Westendorf, Sandra Marten, Christiane Naue, et al.
Thrombosis Journal
|
January 1, 2020
Evaluation of unmet clinical needs in prophylaxis and treatment of venous thromboembolism in at-risk patient groups: pregnancy, elderly and obese patients
Benjamin Brenner, Roopen Arya, Jan Beyer-Westendorf, et al.
Thrombosis Research
|
June 16, 2023
Clinical effectiveness and safety of edoxaban in obese patients - Results of the prospective Dresden NOAC Registry (NCT01588119)
Luise Tittl, Christina Köhler, Sandra Marten, et al.
Thrombosis Research
|
May 27, 2022
Effectiveness and safety of edoxaban therapy in daily-care patients with atrial fibrillation. Results from the DRESDEN NOAC REGISTRY
Christina Köhler, Luise Tittl, Sandra Marten, et al.
Thrombosis and Haemostasis
|
May 22, 2015
Selection, management, and outcome of vitamin K antagonist-treated patients with atrial fibrillation not switched to novel oral anticoagulants. Results from the Dresden NOAC registry
Franziska Michalski, Luise Tittl, Sebastian Werth, et al.
Thrombosis Journal
|
September 7, 2018
COSIMO - patients with active cancer changing to rivaroxaban for the treatment and prevention of recurrent venous thromboembolism: a non-interventional study
Alexander T Cohen, Anthony Maraveyas, Jan Beyer-Westendorf, et al.
Thrombosis Journal
|
April 24, 2019
Evaluation of unmet clinical needs in prophylaxis and treatment of venous thromboembolism in high-risk patient groups: cancer and critically ill
Benjamin Brenner, Russell Hull, Roopen Arya, et al.
Page
of 23